Article History
Received: 11 August 2022
Accepted: 6 February 2023
First Online: 1 March 2023
Conflict of interest
: Dr. Rabinstein has received remuneration as a member of the CEC for clinical trials funded by Boston Scientific and for participating in Advisory Board meetings for Astra Zeneca and Novo Nordisk (all disclosures unrelated to this submission). He also serves as Associate Editor for <i>Neurocritical Care</i>. Dr. Cinotti has received consulting fees for PAION. Dr. Bösel has received speaker honoraria and travel support from Medtronic, Boehringer, Neuroptics, and BMS (all disclosures unrelated to this submission). He has also received a PCORI research award and funding from the DGNI for the design and conduction of the trial SETPOINT2.
: This is a review article. It adheres to ethical standards but does not require institutional review board approval because of its nature.